EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis

Ari G Mandler iD, Christopher T Sciria, Edward V Kogan iD, Ilya Kim iD, Ilhwan Yeo iD, Matthew S Simon, Luke K Kim iD, James E Ip iD, Christopher F Liu iD, Steven M Markowitz, Bruce B Lerman, George Thomas iD und 1 weitere

Europace · 2024

DOI: 10.1093/europace/euae308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Ari G Mandler und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Weill Cornell Medicine-New York Presbyterian Hospital and Weill Cornell Cardiovascular Outcomes Resea…. Hauptthemen laut MEDLINE: Device Removal, Defibrillators, Implantable, Prosthesis-Related Infections, Pacemaker, Artificial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael Wolk Heart Foundation, New York Cardiac Center, Inc., New York Weill Cornell Medical Center Alumni Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Utilization of transvenous lead extraction/removal (TLE) for the management of cardiac implantable electronic device (CIED)-associated infective endocarditis (IE) remains low. The aim of this study was to examine the impact of hospital TLE procedural volume on TLE utilization and outcomes for patients with CIED-associated IE. Methods and results Using the Nationwide Readmissions Database, we evaluated 21 545 admissions for patients (mean age 70 years, 39% female) with CIEDs hospitalized with IE at TLE centres. Hospitals were categorized based on annual volume tertiles: (i) low-volume (1–17 TLEs/year), (ii) medium-volume (18–45 TLEs/year), and (iii) high-volume centres (>45 TLEs/year). Between 2016 and 2019, 57% of admissions in the study were to low-volume TLE centres. Transvenous lead extraction/removal was performed during 6.9, 19.3, and 26% of admissions for CIED-associated IE at low-, medium-, and high-volume TLE centres, respectively (P < 0.001). After adjustment for age and comorbidities, hospitalization for IE at high-volume centres was independently associated with TLE when compared with low-volume centres (adjusted odds ratio 4.26; 95% confidence interval 3.53–5.15). Transvenous lead extraction/removal-associated complication rates were similar at 2.5, 2.3, and 3.4% at low-, medium-, and high-volume centres, respectively (P = 0.493). Overall inpatient mortality during admissions to low-, medium-, and high-volume centres was also similar.

Conclusion

Admissions to high-volume TLE centres were associated with higher utilization of TLE for management of CIED-associated IE. Transvenous lead extraction/removal-associated complications and mortality among patients hospitalized with CIED-associated IE were similar when stratified by hospital TLE volume, but this needs to be considered in context of significant differences in patient comorbidity burden between centres.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Device RemovalDefibrillators, ImplantableProsthesis-Related InfectionsPacemaker, ArtificialHospitals, High-VolumeHospitals, Low-VolumeEndocarditisHumansFemaleMaleAgedUnited StatesMiddle AgedAged, 80 and overDatabases, FactualRisk FactorsPatient ReadmissionRetrospective StudiesTreatment OutcomeHospital Mortality

Stichwörter der Autor:innen

Cardiac implantable electronic deviceInfective endocarditisMortalityTransvenous lead extraction

Autor:innen und Institutionen

  • Department of Medicine, Division of Cardiology, Weill Cornell Medicine-New York Presbyterian Hospital and Weill Cornell Cardiovascular Outcomes Research Group (CORG), 520 East 70th Street 4th Floor, New York, NY 10021,…
  • Department of Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, NY, USA.
  • Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY, USA.

ORCID-Profile: Ari G Mandler, Edward V Kogan, Ilya Kim, Ilhwan Yeo, Luke K Kim, James E Ip, Christopher F Liu, George Thomas, Jim W Cheung

Förderung

  • Michael Wolk Heart Foundation
  • New York Cardiac Center, Inc.
  • New York Weill Cornell Medical Center Alumni Council

Zitieren

APA

Mandler, A. G., Sciria, C. T., Kogan, E. V., Kim, I., Yeo, I., Simon, M. S., Kim, L. K., Ip, J. E., Liu, C. F., Markowitz, S. M., Lerman, B. B., Thomas, G., & Cheung, J. W. (2024). Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis. Europace. https://doi.org/10.1093/europace/euae308

Vancouver

Mandler AG, Sciria CT, Kogan EV, Kim I, Yeo I, Simon MS, et al. Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis. Europace. 2024. doi:10.1093/europace/euae308

BibTeX
@article{Mandler2024,
  author = {Mandler, Ari G and Sciria, Christopher T and Kogan, Edward V and Kim, Ilya and Yeo, Ilhwan and Simon, Matthew S and Kim, Luke K and Ip, James E and Liu, Christopher F and Markowitz, Steven M and Lerman, Bruce B and Thomas, George and Cheung, Jim W},
  title = {Impact of hospital lead extraction volume on management of cardiac implantable electronic device-associated infective endocarditis},
  journal = {Europace},
  year = {2024},
  doi = {10.1093/europace/euae308}
}
Kostenlos starten →